Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Endometrial safety study of drospirenone over 13 contraceptive cycles
2013-002300-13Phase 3Completed
- Sponsor
- Chemo
- Start
- Sep 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of drospirenone in contraception, sponsored by Chemo. Primary endpoint: Endometrial biopsy rating. Started Sep 2013; status: completed.
02
Drugs
drospirenone
03
Conditions
contraception
Beyond the preview
Go deeper on 2013-002300-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-002300-13.